All companies
Visit website
NIGHTWARE INC
UnknownNightWare, Incorporated
Healthcare · Founded 2019
AI-driven, fda-cleared solution for ptsd nightmares
Post-money valuation ⓘ
$22.4M
As of Mar 2025 · from NightWare Inc Preferred Stock 1 · pre-money + amount raised, not a traded price
Total raised
$0
Across 1 round since 2024
Latest share price
$1.16
NightWare Inc Preferred Stock 1 offering price
Financials
FY2022–FY2024 · from SEC filings · hover any figure for its source$2.0M
−$778K
2022
$4.7M
−$275K
2023
$985K
−$1.1M
2024
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022
FY2023
FY2024
Income statement
Revenue
$2,003,698
$4,657,997
$984,653
Cost of goods sold
$498,277
$779,610
$72,242
Gross margin
75%
83%
93%
Net income
-$778,422
-$274,724
-$1,073,507
Taxes paid
$2,778
$139
$22,278
Balance sheet
Cash
$953,836
$2,191,637
$882,737
Accounts receivable
$118,157
$5,000
$6,900
Total assets
$1,383,783
$2,760,813
$1,493,333
Short-term debt
$228,290
$348,212
$167,132
Long-term debt
$1,751,976
$0
$0
Total liabilities
$1,980,266
$348,212
$167,132
Other
Headcount
—
7
7
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Post-money = pre-money + amount raised · caps marked$22.4M
post-money
NightWare Inc Preferred Stock 1
A dashed amber step is a SAFE/note valuation cap — a conversion ceiling agreed for that instrument, not a priced valuation of the company. Steps are not comparable across bases.
Fundraising history
Raised $0 / $1.2MPost-money $22.4M
Reg CF annual-report compliance
Possibly delinquent
Filed 1 of 2 annual reports (FY2024–FY2025)
Missing: 2025
Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.
SEC filings
View all 11 filings on EDGARSource: ManualCIK 0001774677Share price $1.16
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.